Related references
Note: Only part of the references are listed.Liposomal drug delivery systems: From concept to clinical applications
Theresa M. Allen et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Resveratrol pre-treatment reduces early inflammatory responses induced by status epilepticus via mTOR signaling
Sheng-jun Wang et al.
BRAIN RESEARCH (2013)
Resveratrol and Clinical Trials: The Crossroad from In Vitro Studies to Human Evidence
Joao Tomé-Carneiro et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neck
Felix Keil et al.
EUROPEAN JOURNAL OF CANCER (2013)
Dose-Dependent Interaction of trans-Resveratrol with Biomembranes: Effects on Antioxidant Property
Stalin Selvaraj et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Inhibition of Na+-H+ exchange as a mechanism of rapid cardioprotection by resveratrol
Luong Cong Thuc et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Liposomal drug formulations in cancer therapy: 15 years along the road
Marije Slingerland et al.
DRUG DISCOVERY TODAY (2012)
The effect of resveratrol on the prevention of cisplatin ototoxicity
T. Erdem et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2012)
Different Effects of Resveratrol on Dose-Related Doxorubicin-Induced Heart and Liver Toxicity
Jaroslaw Dudka et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2012)
Doxil® - The first FDA-approved nano-drug: Lessons learned
Yechezkel (Chezy) Barenholz
JOURNAL OF CONTROLLED RELEASE (2012)
Role of Akt-Dependent Pathway in Resveratrol-Mediated Cardioprotection after Trauma-Hemorrhage
Yung-Fong Tsai et al.
JOURNAL OF SURGICAL RESEARCH (2012)
Resveratrol in human cancer chemoprevention - Choosing the right' dose
Edwina Scott et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2012)
Cardiovascular effects and molecular targets of resveratrol
Huige Li et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2012)
Revisiting the Isobole and Related Quantitative Methods for Assessing Drug Synergism
Ronald J. Tallarida
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects
Kazuo Maruyama
ADVANCED DRUG DELIVERY REVIEWS (2011)
Cisplatin-based chemoradiation plus cetuximab in locally advanced head and neck cancer: a phase II clinical study
M. Merlano et al.
ANNALS OF ONCOLOGY (2011)
LONG-TERM OUTCOME AND MORBIDITY AFTER TREATMENT WITH ACCELERATED RADIOTHERAPY AND WEEKLY CISPLATIN FOR LOCALLY ADVANCED HEAD-AND-NECK CANCER: RESULTS OF A MULTIDISCIPLINARY LATE MORBIDITY CLINIC
Heidi Rutten et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Enhancement of Cancer Chemosensitization Potential of Cisplatin by Tea Polyphenols Poly(lactide-co-glycolide) Nanoparticles
Madhulika Singh et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2011)
Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial
Jochen H. Lorch et al.
LANCET ONCOLOGY (2011)
Liposome formulation of co-encapsulated vincristine and quercetin enhanced antitumor activity in a trastuzumab-insensitive breast tumor xenograft model
Man-Yi Wong et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2011)
5-Fluorouracil Increases the Chemopreventive Potentials of Resveratrol Through DNA Damage and MAPK Signaling Pathway in Human Colorectal Cancer Cells
Purusottam Mohapatra et al.
ONCOLOGY RESEARCH (2011)
Liposomal cisplatin: a new cisplatin formulation
George P. Stathopoulos
ANTI-CANCER DRUGS (2010)
Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
Ting-Chao Chou
CANCER RESEARCH (2010)
Effects of resveratrol on membrane biophysical properties: relevance for its pharmacological effects
J. Brittes et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2010)
Interaction of the chemopreventive agent resveratrol and its metabolite, piceatannol, with model membranes
Olga Wesolowska et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2009)
Clinical overview on Lipoplatin™: a successful liposomal formulation of cisplatin
Teni Boulikas
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Application of Simplex Lattice Design and Desirability Function for the Formulation Development of Mouth Dissolving Film of Salbutamol Sulphate
Mukesh Gohel et al.
Current Drug Delivery (2009)
Antioxidant properties of resveratrol and piceid on lipid peroxidation in micelles and monolamellar liposomes
Sabrina Fabris et al.
BIOPHYSICAL CHEMISTRY (2008)
Resveratrol displays converse dose-related effects on 5-fluorouracil-evoked colon cancer cell apoptosis - The roles of caspase-6 and p53 (Publication with Expression of Concern. See vol. 21, pg. 767, 2020)
Jason Yongsheng Chan et al.
CANCER BIOLOGY & THERAPY (2008)
Drug binding and mobility relating to the thermal fluctuation in fluid lipid membranes
Emiko Okamura et al.
JOURNAL OF CHEMICAL PHYSICS (2008)
Differential Scanning Calorimetry (DSC): A tool to study the thermal behavior of lipid bilayers and liposomal stability
Costas Demetzos
JOURNAL OF LIPOSOME RESEARCH (2008)
Effects of poly (ethylene glycol) chains conformational transition on the properties of mixed DMPC/DMPE-PEG thin liquid films and monolayers
Georgi As. Georgiev et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2007)
Interaction of resveratrol and its trimethyl and triacetyl derivatives with biomembrane models studied by differential scanning calorimetry
Maria Grazia Sarpietro et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2007)
New-concept chemotherapy by nanoparticles of biodegradable polymers: where are we now?
Si-Shen Feng
NANOMEDICINE (2006)
Size and stability of liposomes: A possible role of hydration and osmotic forces
J. Sabin et al.
EUROPEAN PHYSICAL JOURNAL E (2006)
Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies
Ting-Chao Chou
PHARMACOLOGICAL REVIEWS (2006)
Effect of ion-binding and chemical phospholipid structure on the nanomechanics of lipid bilayers studied by force spectroscopy
S Garcia-Manyes et al.
BIOPHYSICAL JOURNAL (2005)
Skin toxicity associated with pegylated liposomal doxorubicin (40 mg/m2) in the treatment of gynecologic cancers
RJ Kim et al.
GYNECOLOGIC ONCOLOGY (2005)
Drug interaction and location in liposomes: correlation with polar surface areas
GMM El Maghraby et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer
J Bernier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Modeling and comparison of dissolution profiles
P Costa et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2001)
Share Paper
